| DAA76 |
enolase 3 (beta, muscle) |
ENO3 |
38.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA77 |
endosulfine alpha |
ENSA |
9.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA78 |
fatty acid desaturase 1 |
FADS1 |
7.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA79 |
fumarylacetoacetate hydrolase (fumarylacetoacetase) |
FAH |
10.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA8 |
angiomotin |
AMOT |
10.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA80 |
family with sequence similarity 49, member A |
FAM49A |
16.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA81 |
fibroblast growth factor 1 (acidic) |
FGF1 |
20.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA82 |
fibroblast growth factor 12 |
FGF12 |
29.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA83 |
fibroblast growth factor 13 |
FGF13 |
28.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA84 |
fibroblast growth factor 2 (basic) |
FGF2 |
12.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA849 |
telomere shortening |
— |
— |
liver |
Human |
|
| DAA85 |
fibroblast growth factor receptor 3 |
FGFR3 |
13.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA86 |
mechanistic target of rapamycin (serine/threonine kinase) |
MTOR |
7.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA87 |
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
GABRB3 |
31.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA877 |
Higher oxidation and decreased proteasome activity |
— |
— |
epidermis |
Human |
|
| DAA88 |
gamma-aminobutyric acid (GABA) A receptor, delta |
GABRD |
9.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA89 |
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
GATM |
8.0% Increase Gene Expression Level |
brain |
Human |
|
| DAA890 |
IgM deposition in glomeruli |
— |
— |
glomerulus |
Human |
|
| DAA9 |
ankyrin 2, neuronal |
ANK2 |
20.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA90 |
GDNF family receptor alpha 2 |
GFRA2 |
6.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA901 |
telomere shortening |
— |
— |
kidney |
Human |
|
| DAA902 |
specific activities of enzymes are reduced |
— |
— |
kidney |
Human |
|
| DAA91 |
guanine nucleotide binding protein (G protein), beta polypeptide 1 |
GNB1 |
4.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA92 |
guanine nucleotide binding protein (G protein), beta 5 |
GNB5 |
17.0% Decrease Gene Expression Level |
brain |
Human |
|
| DAA93 |
guanine nucleotide binding protein (G protein), gamma 11 |
GNG11 |
23.0% Increase Gene Expression Level |
brain |
Human |
|